Volunteers Needed for Tuberculosis Test Study
The Center for Vaccine Development is conducting a research study to assess a new diagnostic test for tuberculosis (TB) infection and is seeking study volunteers.
About the Study
The purpose of this clinical trial is to assess a new diagnostic test for TB infection. It is estimated that about one-third of the world’s population is infected with Mycobacterium tuberculosis, the bacterium that causes TB.
While some people become very sick after infection (active TB), most show no signs or symptoms of having TB and are not contagious. Such a case is referred to as latent tuberculosis infection (LTBI), which can become active TB, when a person’s immune system is impaired.
Accurate and early diagnosis of persons with LTBI is important to stop the spread of TB. This new product may help identify the presence of TB in persons with active TB or LTBI.
- Participants must be older than 18.
- Volunteers must not have or test positive for TB.
- Participation is strictly voluntary.
- Selected volunteers will be compensated at $75 per clinic visit.
The study’s Institutional Review Board (IRB) protocol number is #17553 and the protocol was approved on Dec. 23, 2019.
Daniel F. Hoft, M.D., Ph.D., is the study’s principal investigator.